Cite

HARVARD Citation

    Ben‐Ami, E. et al. (2017). Immunotherapy with single agent nivolumab for advanced leiomyosarcoma of the uterus: Results of a phase 2 study. Cancer. 123 (17), pp. 3285-3290. [Online]. 
  
Back to record